President Samia Suluhu Outlines Africa’s Sovereignty in the Global Fight Against Malaria

President Samia Suluhu Hassan champions African-led genetic research and local manufacturing as the keys to a malaria-free future.

By: AXL Media

Published: May 1, 2026, 8:01 AM EDT

Source: Information for this report was sourced from The Star (Kenya)

The Shift to Genetic Mosquito Control

In a comprehensive op-ed marking 2026 malaria elimination milestones, President Samia Suluhu Hassan advocated for the integration of genetic methods to combat evolving mosquito resistance. While existing tools like insecticide-treated nets and vaccines remain essential, the President noted that genetic approaches—designed to either prevent mosquitoes from transmitting the parasite or to reduce their populations—represent the next frontier. She highlighted that mathematical simulations suggest gene drive technology could reduce malaria-carrying mosquitoes by 72% to 98%, offering a critical supplement to traditional vector control.

African Science and Sovereignty

A central theme of the President's address was the importance of "African sovereignty" in scientific research. She pointed to the Ifakara Health Institute in Tanzania and the Uganda Virus Institute as primary examples of African scientists leading high-stakes research. Through programs like Transmission Zero and Target Malaria, African researchers are building the evidence base for these new technologies. President Hassan asserted that sovereignty in this context means owning the decisions, the accountability, and the eventual deployment of these tools, ensuring they are co-created with the communities they are meant to protect.

The "Manufacturing Bridge" and Local Production

Addressing the supply chain vulnerabilities exposed during the COVID-19 pandemic, the President emphasized that innovation is only effective if it reaches the public affordably. Currently, Africa imports 99% of its vaccines and 95% of its medicines. To counter this, Tanzania has launched a Pharmaceutical Investment Acceleration Strategy, creating manufacturing hubs in the Coast and Dar es Salaam regions. With $10 million invested in shared laboratory infrastructure, Tanzania is fast-tracking the production of biolarvicides and next-generation nets, aiming to shorten the distance between the laboratory and the village.